A key trend shaping the Prosthetic Heart Valve Devices And Equipment Market involves the Innovative Product Developments By Leading Companies In The Prosthetic Heart Valve Devices Market

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Prosthetic Heart Valve Devices And Equipment Market Expected To Change Between 2026 And 2030?

The prosthetic heart valve devices and equipment market has shown significant growth in recent years. It is anticipated to increase from $6.73 billion in 2025 to $7.17 billion in 2026, at a compound annual growth rate (CAGR) of 6.5%. This historical expansion can be attributed to several factors including the rising prevalence of valvular heart diseases, an aging global population, the expansion of cardiac surgery programs, increasing adoption of valve replacement procedures, and advancements in cardiac imaging technologies.

The market size for prosthetic heart valve devices and equipment is projected to experience substantial growth in the upcoming years. It is predicted to expand to $10.48 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 9.9%. This anticipated growth is driven by factors such as an increasing preference for minimally invasive cardiac interventions, a rising demand for longer-lasting valve implants, the expansion of transcatheter valve indications, growing investments in structural heart disease treatment, and increasing innovation in biological valve materials. Significant trends during the forecast period are expected to include the increasing adoption of transcatheter heart valve procedures, a rising demand for tissue-based heart valves, the growing use of minimally invasive valve repair systems, the expansion of advanced valve durability technologies, and an enhanced focus on patient-specific valve solutions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2416&type=smp

Which Major Factors Are Driving The Expansion Of The Prosthetic Heart Valve Devices And Equipment Market?

The growing occurrence of valvular heart disease has fueled the requirement for transcatheter aortic valve replacement (TAVR) procedures, thereby stimulating the prosthetic heart valve devices and equipment market. TAVR is a minimally-invasive surgical process carried out to treat aortic stenosis, a valvular heart disease that affects the heart’s aortic valve. Aortic stenosis hardens the aortic valve, preventing proper blood flow, and TAVR is utilized to replace this faulty aortic valve with a transcatheter valve. For instance, in May 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, over 695,000 people in the US died from heart disease, accounting for one out of every five deaths. As the prevalence of valvular heart diseases rises, the volume of TAVR procedures performed is expected to increase, which in turn boosts the demand for transcatheter valves, thus driving the market moving forward.

How Is The Prosthetic Heart Valve Devices And Equipment Market Structured Across Different Segments?

The prosthetic heart valve devices and equipment market covered in this report is segmented –

1) By Product Type: Repair Products, Mitral Valve Repair Devices, Tricuspid Valve Repair Devices

2) By Valve Type: Transcatheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve

3) By Technology: Biological Valve, Decellularized Valve

4) By Application: Hospitals, Ambulatory Surgery Centres

Subsegments:

1) By Repair Products: Transcatheter Mitral Valve Repair (TMVR) Devices, Transcatheter Tricuspid Valve Repair (TTVR) Devices

2) By Mitral Valve Repair Devices: Mitral Valve Repair Systems (MitraClip), Mitral Valve Annuloplasty Devices, Edge-to-Edge Repair Devices

3) By Tricuspid Valve Repair Devices: Tricuspid Valve Annuloplasty Devices, Tricuspid Valve Repair Systems

Which Trends Are Shaping The Future Of The Prosthetic Heart Valve Devices And Equipment Market?

Leading companies in the prosthetic heart valve devices and equipment market are focused on developing tricuspid valve replacement systems. This initiative aims to meet the increasing demand for effective treatments for tricuspid valve disease, enhance patient outcomes, and mitigate complications associated with traditional heart valve surgeries. These tricuspid valve replacement systems refer to medical devices specifically engineered to replace the heart’s tricuspid valve, which regulates blood flow between the right atrium and right ventricle. For example, in October 2023, Edwards Lifesciences, a US-based technology company, secured CE Mark approval for its EVOQUE system, establishing it as the world’s first transcatheter valve replacement therapy approved for treating tricuspid regurgitation (TR). The EVOQUE valve is characterized by a nitinol self-expanding frame and tissue leaflets derived from bovine pericardial tissue. It is designed for delivery via a low-profile transfemoral 28-French system and will be made available in three sizes.

Which Major Players Dominate The Prosthetic Heart Valve Devices And Equipment Market?

Major companies operating in the prosthetic heart valve devices and equipment market are Boston Scientific Corporation, Edwards Lifesciences, Medtronic plc, LivaNova plc, Abbott Laboratories, Jenavalve Technology Inc., Lepu Medical Technology, Cryolife Inc., Neovasc Inc., Braile Biomedica, Colibri Heart Valve, TTK Healthcare Ltd., Medical Technology Est., Micro Interventional Devices Inc., Well Health Technologies, On-X Life Technologies Inc., Meril Life Sciences Pvt. Ltd., Sorin Group, Commonwealth Edison Company, Cardiac Dimensions Inc., CardioSolutions Inc., Leman Cardiovascular, MitralSolutions Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Xeltis AG, Transcatheter Technologies GmbH, Venus Medtech (Hangzhou) Inc., MValve Technologies Ltd., MVRx Inc., NaviGate Cardiac Structures Inc., Pulmonx Corporation, Tendyne Holdings Inc., ValveXchange Inc., Vascutek Ltd., XpandOrtho Inc., Zhejiang A&F Medical Co. Ltd.

Read the full prosthetic heart valve devices and equipment market report here:

https://www.thebusinessresearchcompany.com/report/prosthetic-heart-valve-devices-and-equipment-global-market-report

Which Region Currently Holds The Largest Share Of The Prosthetic Heart Valve Devices And Equipment Market?

North America was the largest region in global prosthetic heart valve devices and equipment market in 2025. Western Europe was the second-largest region in prosthetic heart valve devices and equipment market. The regions covered in the prosthetic heart valve devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Prosthetic Heart Valve Devices And Equipment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2416&type=smp

Browse Through More Reports Similar to the Global Prosthetic Heart Valve Devices And Equipment Market 2026, By The Business Research Company

Cardiac Prosthetic Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-prosthetic-devices-global-market-report

Cardiovascular Surgery Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Heart Pump Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/heart-pump-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795